5 fast facts about Paragon 28’s Q2 report

Foot and ankle orthopedic medical device company Paragon 28 reported $42.5 million in revenue in the second quarter, up 19 percent from the same period last year. 

Advertisement

Five fast facts worth noting: 

1. Revenue growth: U.S. revenue grew 19 percent to $36.8 million, while international revenue reached $5.7 million. 

2. Gross margin: Paragon 28 saw an 82 percent gross margin, up from 81.3 percent last year.  

3. Operating expenses: Paragon 28’s operating expenses reached $43.9 million, up from $43 million last quarter. 

4. Losses: Paragon 28 had a net loss of $9.6 million. 

5. Future growth: Paragon 28 aims to reach a net revenue of $42.5 million in quarter three and $49.6 million in quarter four. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.